Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adenylate kinase 2 is a biomarker related to the prognosis of glioma and the immune microenvironment.

Journal of clinical laboratory analysis - 1 Apr 2023

Liu Zhichen, Tang Chunjiao, Teng Xu, Mohamed Zakaria Ahmed, Fan Jingyi

Abstract excerpt

BACKGROUND: Among the brain and the other central nervous system, gliomas are the most prevalent malignant primary tumors. Adenylate kinase 2 (AK2) is generally thought to be crucial for energy metabolism and signal transduction. Several disorders are correlated with its aberrant expression. However, it is unclear what functions AK2 might have in gliomas. METHODS: We investigated the relationship between AK2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Brain Neoplasms
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 37161605
DOI: 10.1002/jcla.24892
PMCID: PMC10290226

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adenylate kinase 2 is a biomarker related to the prognosis of glioma and the immune microenvironment.PMID 37161605Read ↗

Prognostic value and immunological role of Adenylate Kinase 2 in human gliomaSemantic proximity Read ↗

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for GliomaSemantic proximity Read ↗

The role of the adenylate kinase 5 gene in various diseases and cancerSemantic proximity Read ↗

Immune-related genes with APA in microenvironment indicate risk stratification and clinical prognosis in grade II/III gliomasSemantic proximity Read ↗

Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in gliomaSemantic proximity Read ↗

ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppressionSemantic proximity Read ↗

A thorough pan-cancer analysis and experimental confirmation of the function of adenylosuccinate lyase in gliomaSemantic proximity Read ↗

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including GliomasSemantic proximity Read ↗

ANXA2 is Correlated With the Molecular Features and Clinical Prognosis of Glioma, and Acts as a Potential Marker of ImmunosuppressionSemantic proximity Read ↗

Comprehensive Analysis Reveals Promising Immune Target and Prognostic Value of PLK3 in GliomaSemantic proximity Read ↗

RNASE2 is a prognostic biomarker and is correlated with immune infiltration in gliomaSemantic proximity Read ↗

Molecular and clinical features of a potential immunotherapy target ELK3 in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.